Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 3 (ZNF3) is a member of the C2H2-type zinc finger transcription factor family that enables DNA binding and identical protein binding activity; it is predicted to regulate transcription by RNA polymerase II and is primarily active in the nucleus. ZNF3 is implicated in cell differentiation and proliferation. Diseases genetically associated with alterations in ZNF3 include certain bleeding disorders and maturity-onset diabetes of the young, though there is little evidence for direct targeting or therapeutic modulation of ZNF3 by drugs[1][3][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 3 (ZNF3).